Michael Gattens

2.6k total citations
9 papers, 121 citations indexed

About

Michael Gattens is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Gattens has authored 9 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Genetics and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Gattens's work include Acute Myeloid Leukemia Research (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Michael Gattens is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Michael Gattens collaborates with scholars based in United Kingdom, United States and Canada. Michael Gattens's co-authors include Ri Liesner, Marie Scully, Kate Khair, Jennifer C. Hartle, John D. Grainger, Matthew J. Murray, Rachel Williams, Carlo L. Acerini, Vickie McDonald and Samuel J. Machin and has published in prestigious journals such as Blood, British Journal of Cancer and British Journal of Haematology.

In The Last Decade

Michael Gattens

9 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Gattens United Kingdom	7	61	56	34	34	33	9	121
Tim Prestidge New Zealand	6	58 1.0×	46 0.8×	12 0.4×	10 0.3×	19 0.6×	8	116
Jenni Heikkinen‐Eloranta Finland	6	25 0.4×	137 2.4×	21 0.6×	53 1.6×	34 1.0×	10	211
Humphrey Pullon New Zealand	6	49 0.8×	60 1.1×	28 0.8×	19 0.6×	9 0.3×	11	114
Elena Guggiari Italy	5	117 1.9×	13 0.2×	13 0.4×	13 0.4×	12 0.4×	9	134
Francisco Bracho United States	6	33 0.5×	33 0.6×	19 0.6×	9 0.3×	18 0.5×	12	96
Elizabeth Chalmers United Kingdom	3	186 3.0×	81 1.4×	64 1.9×	15 0.4×	6 0.2×	3	248
Nobuo Sezaki Japan	7	48 0.8×	26 0.5×	18 0.5×	12 0.4×	34 1.0×	13	104
A Urbano Ispizua Spain	4	121 2.0×	18 0.3×	38 1.1×	31 0.9×	50 1.5×	6	174
Stefano Pasquali Italy	4	60 1.0×	12 0.2×	9 0.3×	15 0.4×	10 0.3×	11	168
Alyssa Clay‐Gilmour United States	8	38 0.6×	21 0.4×	7 0.2×	11 0.3×	28 0.8×	17	132

Countries citing papers authored by Michael Gattens

Since Specialization

Citations

This map shows the geographic impact of Michael Gattens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gattens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gattens more than expected).

Fields of papers citing papers by Michael Gattens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gattens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gattens. The network helps show where Michael Gattens may publish in the future.

Co-authorship network of co-authors of Michael Gattens

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gattens. A scholar is included among the top collaborators of Michael Gattens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gattens. Michael Gattens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Connor, Philip, Michelle Cummins, Michael Gattens, et al.. (2024). Blinatumomab with De-Escalated Chemotherapy for Infant KMT2A-Rearranged B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 2816–2816. 3 indexed citations

Coorens, Tim, Grace Collord, Emily Mitchell, et al.. (2021). Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment. Blood. 137(21). 2992–2997. 17 indexed citations

Mitchell, Michael, Michael Gattens, Kaan Kavaklı, et al.. (2018). Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiency. Blood Coagulation & Fibrinolysis. 30(1). 34–41. 7 indexed citations

Gattens, Michael, et al.. (2014). G255(P) Iron overload in Paediatric Haematology and Oncology. Archives of Disease in Childhood. 99(Suppl 1). A111–A111. 1 indexed citations

Gattens, Michael, et al.. (2013). Non‐irradiated female survivors of childhood acute lymphoblastic leukaemia are at risk of long‐term increases in weight and body mass index. British Journal of Haematology. 163(4). 510–513. 9 indexed citations

Williams, Rachel, et al.. (2011). Auxological changes in UK survivors of childhood acute lymphoblastic leukaemia treated without cranial irradiation. British Journal of Cancer. 104(5). 746–749. 18 indexed citations

McDonald, Vickie, Ri Liesner, John D. Grainger, et al.. (2010). Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays. Blood Coagulation & Fibrinolysis. 21(3). 245–250. 17 indexed citations

Perry, David J., et al.. (2006). Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain. Haemophilia. 12(6). 621–624. 9 indexed citations

Scully, Marie, Michael Gattens, Kate Khair, & Ri Liesner. (2006). The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura. British Journal of Haematology. 135(1). 101–104. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact